Symptoms of Advanced Stage Prostate Cancer

Prostate cancer is a kind of dangerous diseases to be afraid of by almost all of adult men. Well, since it is particularly affecting the system of reproduction and even digestion, therefore, you may imagine that it will simply damage the patients' life. Although it is known that this type of cancer is often producing certain symptoms, in fact, there are also many people that don't feel any signs at all just before being diagnosed. But if you notice well, there are several matters that can indicate that you are one of the next prostate cancer just by only seeing several signs and also noticing your lifestyle.

Here are several things that you should aware so much, since they can be several undetected symptoms of prostate cancer. Just check them out.

Frequent Urination

Well, the first thing that you should consider well is regarding the dying for a pee, particularly at night. It is actually something which is common to be experienced if your water consumption tends to be higher. But of course, if you think you are not drinking too much before sleeping, surely, it is something that you should pay attention. Besides, another symptom is that you find it rather difficult when starting to pee or even you feel it pain. Yes, if you have experienced such things, you should then better visit the doctor.

Blood in Your Urine

In a higher level, you will find that there is blood in your urine. Of course, there are actually several other diseases that have such symptoms like reproduction infection. Therefore, if you already have such experiences, it is much better also to go to the doctor to ask for any diagnose.

Erectile Difficulties

Another symptom that you swill find while being a patient of prostate cancer is about the disorder within your sexual organ. One of them is the erectile difficulty. Many adult men then assume and decide to consume such vitality medicine to solve this problem. It is surely no matter at all if you are normal, but if it is then a symptom of prostate cancer, it will be more dangerous. Again, going to the doctor firstly before consuming something is much better.

Feeling Pain While Ejaculating

Well, if you think your sexual activities with your wife has been disturbed for something unpleasant like pain while ejaculating, therefore, you should pay attention more. Almost all the disorders occurred within the prostate will produce such symptom, so that being careful is really important.

Backache, Sore Hip and Thighs

You should not underestimate the pain on several areas of your body, including the back, hip and thighs. Yes, although you may think that it is not so much different with the effects of tiredness or something, surely, it is better then to ask any diagnose from the doctor, since it can be one of the symptoms of prostate cancer.

Overall, the symptoms explained above are not so much different with any insignificant diseases. It is probably being the main reason why many people prefer ignoring them. Mainly for you the men above the 50 years old who are more susceptible for the prostate cancer, you should then regularly check your health, particularly if you have experienced such symptoms.

Wendy H. Hood is a blogger who interested on prostate cancer . More information about this topic can be found online on her website.

View the original article here

Symptoms of Advanced Stage Prostate Cancer

Prostate cancer is a kind of dangerous diseases to be afraid of by almost all of adult men. Well, since it is particularly affecting the system of reproduction and even digestion, therefore, you may imagine that it will simply damage the patients' life. Although it is known that this type of cancer is often producing certain symptoms, in fact, there are also many people that don't feel any signs at all just before being diagnosed. But if you notice well, there are several matters that can indicate that you are one of the next prostate cancer just by only seeing several signs and also noticing your lifestyle.

Here are several things that you should aware so much, since they can be several undetected symptoms of prostate cancer. Just check them out.

Frequent Urination

Well, the first thing that you should consider well is regarding the dying for a pee, particularly at night. It is actually something which is common to be experienced if your water consumption tends to be higher. But of course, if you think you are not drinking too much before sleeping, surely, it is something that you should pay attention. Besides, another symptom is that you find it rather difficult when starting to pee or even you feel it pain. Yes, if you have experienced such things, you should then better visit the doctor.

Blood in Your Urine

In a higher level, you will find that there is blood in your urine. Of course, there are actually several other diseases that have such symptoms like reproduction infection. Therefore, if you already have such experiences, it is much better also to go to the doctor to ask for any diagnose.

Erectile Difficulties

Another symptom that you swill find while being a patient of prostate cancer is about the disorder within your sexual organ. One of them is the erectile difficulty. Many adult men then assume and decide to consume such vitality medicine to solve this problem. It is surely no matter at all if you are normal, but if it is then a symptom of prostate cancer, it will be more dangerous. Again, going to the doctor firstly before consuming something is much better.

Feeling Pain While Ejaculating

Well, if you think your sexual activities with your wife has been disturbed for something unpleasant like pain while ejaculating, therefore, you should pay attention more. Almost all the disorders occurred within the prostate will produce such symptom, so that being careful is really important.

Backache, Sore Hip and Thighs

You should not underestimate the pain on several areas of your body, including the back, hip and thighs. Yes, although you may think that it is not so much different with the effects of tiredness or something, surely, it is better then to ask any diagnose from the doctor, since it can be one of the symptoms of prostate cancer.

Overall, the symptoms explained above are not so much different with any insignificant diseases. It is probably being the main reason why many people prefer ignoring them. Mainly for you the men above the 50 years old who are more susceptible for the prostate cancer, you should then regularly check your health, particularly if you have experienced such symptoms.

Wendy H. Hood is a blogger who interested on prostate cancer . More information about this topic can be found online on her website.

View the original article here

Dr. Gary McClain of JustGotDiagnosed.com Addresses Prostate Cancer...

New York, NY (PRWEB) July 09, 2013

Dr. Gary addressed a meeting of the Us TOO prostate cancer support group in Sierra Vista, AZ via Skype on June 28, 2013. A specialist in the emotional impact of chronic and catastrophic illnesses, Gary McClain, PhD, developed JustGotDiagnosed.com to address a serious need he saw going unfulfilled; namely, a way for newly-diagnosed patients to receive help in coping with their emotional reactions to their diagnosis. Dr. McClain also blogs on the patient social networking site, AllianceHealth.com.

Dr. McClain’s presentation focused on the psychosocial aspects of prostate cancer treatment and ongoing adjustment after treatment. Topics included emotional self-care, the importance of emotional support, stress management, and communicating with family members. Attendees included men who were currently being treated for prostate cancer, or had completed treatment, as well as their partners. Us TOO is an international prostate cancer and education support with 325 support group chapters worldwide.

“This was an incredible experience,” Dr. McClain said. “It is so gratifying to talk to a group of individuals who are so receptive to the message of emotional support and communicating with family members after cancer treatment.

“A lot of emotions come up along the cancer survivorship journey,” McClain continued, “and patients don’t always have an opportunity to talk about how they are feeling. Uncertain about the future, for example. And facing additional chronic conditions. Family members are often attempting to cope with their own emotions, and their own feelings of fear and helplessness. Yet, being the ‘strong, silent type’ leaves patients feeling alone and unsupported during a vulnerable time.”

“And to be able to do this via Skype is truly a technology miracle,” McClain concluded.

About Dr. Gary McClain and JustGotDiagnosed.com
Dr. Gary McClain is a therapist, educator, patient advocate and author who specializes in working with individuals who have been diagnosed with chronic and catastrophic medical conditions, focusing on issues that include coping emotionally, gathering information, making lifestyle and treatment decisions, managing relationships, and communicating with healthcare professionals. As "Dr. Gary," he blogs on patient social networking boards on AllianceHealth.com. Founded and developed by Dr. McClain, JustGotDiagnosed.com offers information, guidance and inspiration for newly diagnosed patients, their caregivers, and healthcare professionals. His program for newly-diagnosed patients, Prepared for the Road Ahead ?, is focused on emotions, lifestyle management, communications, and vision for the future. Visit JustGotDiagnosed.com.

Us TOO International Prostate Cancer Education & Support Network is a grassroots, registered 501(c)(3) non-profit prostate cancer education and support network of 325 support group chapters worldwide, providing men and their families with free information, materials and peer-to-peer support so they can make informed choices on detection, treatment options and coping with ongoing survivorship. The organization was founded in 1990 by five men who had been treated for prostate cancer. The mission of Us TOO is to help men and their families make informed decisions about prostate cancer detection and treatment through support, education and advocacy.

View the original article here

New online course examines mouse as a model for prostate cancer

Davis, CA (press BOX) 10 July 2013

Coming soon! UC Davis extension landmark online series, Pathobiology of the mouse which has received several national awards in the past three years, will add a new course this year - mouse as a model for prostate cancer. Dr. Robert D. Cardiff, m.d., Ph.d., UC Davis Distinguished Professor Emeritus and employees continue to developed skills through their content and detailed to facilitate online discussion.

The Pathobiology of which mouse program consists of two levels: I, technicians, and all level work with GEM and level II for enrolled students and doctors, designed, M.D.s. mouse as a model for prostate cancer is the second place in stage II.

Summer and fall courses are listed, to register with http://extension.ucdavis.edu:

Stage IA, Pathobiology of the mouse: Register now through September 27 students have 15 weeks to complete the course. $1,250 Tuition /$ 1,000 for students.

Stage IB, Pathobiology of the mouse: You sign up now through September 27 $1,350 tuition /$ 1,080 for students.

Level II, mouse as a model for the mammary gland cancer: Register 27 $2,295 tuition/1,836 for PhD students now through September

Other courses in development for level II include toxicological pathology, leukemia, lymphoma, and much more.

Mouse Pathobiology training modules are now available. These short, self-taught modules created by content in the landmark Pathobiology of the mouse, stages IA and IB, and between 3-8 take hours to complete. These modules may be taken to fulfill continuing medical education credits.

Information on discounts for groups of three or more, or licensing opportunities please contact Howard Mahoney (530-757-8512; hsmahoney(at)ucdavis(dot)edu)

A free online information event is available at http://extensiondlc.net/infosite/GNP100/player.html.

A free video explains the program is available at http://youtube.com/watch?v=QgoPOybUFFc.

Close the genomic revolution and today to register!

Accreditation
This activity is planned and implemented in accordance with the essential areas and policies of the Accreditation Council for continuing medical education (ACCME) through the joint promotion of the extension was University of California, Davis health system and the UC Davis. The University of California, Davis health system is accredited by the ACCME to medical training for doctors.

Doctor loan
The University of California, Davis health system designates this live activity for maximum 12 AMA PRA category 1 credits ?. physicians should make only credit according to assert the extent of their participation in the activity.

View the original article here

Ways to Reduce the Risk of Prostate Cancer

In the event the women tend to be afraid of to be the suspect of breast or cervical cancer, consequently, prostate cancer is something actually destructive for a lot of adult males. Without a doubt, almost all males above the 50 are having precisely the same danger of being the patients of this kind of cancer. Not just is it troubling your activities too much, it may also result the death for the chronic situations. Nevertheless, instead of you have to waste more money and energy just for this, it's significantly better for you to prevent it as quickly as you can. Here are various things that you should do to maintain your reproduction system healthy even while decreasing the potential of being the patient of prostate cancer. For this reason, just check them out.

Drinking Pure Water Frequently

Pure water treatment is among the most effective approaches if you prefer to keep away from any high-risk illnesses, like prostate cancer. Because it can merely smooth the urinary system, then you're able to diminish the risk of this type of cancer just a long day before. Certainly, it can also recharge your body to ensure that the risks of other illnesses can also be reduced very easily.

Diet for Prostate Cancer

This kind of diet is especially a program developed for adult males who prefer diminishing the threat of prostate cancer since young age. Of course, there are various kinds of foods that should be avoided such as the red meat. There's a study that correlates the high consumption of red meat and also the chance of prostate cancer. However, it really is much better for you to consume more fruits, vegetables, oatmeal and cereals. The nuts can also be good to be consumed since it could boost the amount of protein on your body. Apart from, since it's containing the antioxidant substance, it's so significantly better to prevent cancer.

Increasing the Zinc Consumption

The prostate gland mostly needs the containing of zinc rather than other organs in your entire body. It's primarily functioned to adjust the steroid hormone metabolism so that decrease the risk of prostate swelling. This substance is particularly contained in a number of types of foods and dishes just like the grains. Well now, it truly is time for you to use the grains or cereals as your primary carbohydrate resource.

Consuming More Vitamin

Aside from the protein or carbohydrate from the grains, there is certainly another matter that you need to consume more; it's relating to the vitamin D and E. Those types of vitamin are called one of the most efficient ways that you simply need to try to reduce the chance of prostate cancer.

Exercise Regularly

Putting on a healthy lifestyle looks not complete without you do such workout regularly. Physical exercise implies that you can just run over the area near your house or head to the gymnastic. This activity is helping you so much in maintaining your reproduction area healthy; consequently, you'll be able to basically diminish the risk of being the patient of prostate cancers.

Although it has been described above that prostate cancer is mainly targeting the adult men over 50, it is also any possibility that it could lash out the younger men. As a result, it is not deniable that the healthy lifestyles mentioned above should be employed as quickly as you can.

I'm a free blogger that interested on prostate cancer. This article will guide you of the things that you should do to avoid the prostate cancer.

View the original article here

Cure Prostate Cancer at a Prostate Cancer Treatment Center

Prostate cancer is one of the most common types of cancer found in men. The exact number of patients suffering from this worldwide is immense. According to the American Cancer Society, in 2013, the total number of patients diagnosed with this type of cancer is expected to touch 238,590 only in USA. However, the good news is that, according to the latest reports, more than 2.5 million men in USA who have been diagnosed with it during their lifetime, are leading a healthy life today. It simply means that prostate cancer is not a death sentence. It is treatable and totally curable when diagnosed at an early stage.

Prostate cancer is a condition in which the cells of the prostate gland present in the male reproductive system becomes malignant and shows unnatural growth at the cost of the surrounding normal cells. Timely detection and the right treatment can completely cure this condition and help the patient get back to his normal life within months. However, it is essential that the treatment precise. A good treatment center plays a vital role at this point. The best treatment not only requires the best oncologists with experience in treating prostate cancer but also the use of a state of the art infrastructure to perform the necessary surgeries. A prominent treatment center offers the latest technology driven procedures for the treatment and surgery of prostate cancer.

These centers house the best and renowned oncologists who deliver optimal treatment for prostate cancer. As in most of these cases, elderly men that get it, are treated in a way to maintain a comfortable atmosphere for these patients so that they are not mentally strained and feel at ease while under treatment. They also make a point to offer their services at highly competitive pricing, with different easy payment options available. Check the website of the providers to know in details.

The exact reason behind prostate cancer is still unknown. However, early detection makes a cure possible. According to recent data, the expected 5-year survival rate for men suffering from prostate cancer is almost 100% while the 10-year survival rate is 91%. This is possible because of early detection, improvement in treatment procedures, and salvage hormone therapy.

Early detection of prostate cancer leads to increased chances of a cure, as is the case with many other types. All men over the age of 40 should go for annual screening exams including a PSA (Prostate Specific Antigen) blood test and a DRE (Digital Rectal Exam) in order to make this detection possible.

About Author
Dr. Echt and his team at the Prostate Seed Institute offer the most highly sophisticated methods of radiation therapy available in the United States, equal to that found in major medical centers and academic settings. These include prostate seed implantation, high dose radiation implants, and external beam radiation with image-guided and intensity-modulated (IGRT and IMRT) capabilities. Rate this Article

Cure Prostate Cancer at a Prostate Cancer Treatment CenterNot Rated Yet

Rheta Echt has published 2 articles. Article submitted on July 26, 2013. Word count: 422

Many things in this world were discovered in order to improve the way of living, to keep human race away from any kind of danger, but they turned out to be the great enemy of the same race.

Written by: Cullen Nedrich

Here are some important descriptions about the treatment center as well as their programs that will help you finding a best one according to the needs.

Written by: Pratap Ranjan

Physicians who treat opioid addiction also have the option of utilizing "medication-assisted treatment," and the most common medications used in the treatment of opioid dependence today are methadone, naltrexone, and buprenorphine (Suboxone).

Written by: Dr Jeffrey Stuckert

Millions of individuals suffer from alcohol or drug addiction these days, with only a handful of them seeking professional help for addiction treatment in a drug rehab center. There are thousands of addiction rehab centers throughout the United States,

Written by: John Harper

View the original article here

Treatment Options for Prostate Cancer

Prostate-related Cancer Treatment Methods

Effective prostate cancer treatment depends on several factors. Depending on how advanced the cancer is or how quickly it is spreading, your treatment options could range from simply monitoring the problem to undergoing aggressive radiation treatment.

Each treatment has its advantages and disadvantages, and what proves effective for one cancer patient may not work at all for someone else. As always, it's best for anybody who has been diagnosed with prostate cancer to find a treatment that works best for them, something that may be easier said than done.

Monitoring the Cancer

Some men who have been diagnosed with prostate cancer may not need immediate treatment, or in fact any treatment at all. Benign prostate tumors can develop, and when they do many doctors recommend watchful waiting or active surveillance. This entails monitoring the growth via blood tests, rectal exams or biopsies. This is typically an alternative for prostate cancer that has yet to spread out or might never ever spread, however it is additionally made use of for men that have other health conditions that can be worsened by the negative side effects of additional aggressive cancer therapies.

Radiation Therapy

If a patient's prostate cancer is indeed spreading, it will require some form of treatment. One option for prostate cancer treatment that has proven effective for many patients is radiation therapy. Radiation therapy entails the usage of high-powered radiation to eliminate cancer cells and it could be provided to the client's body in either methods by which. The very first is external beam radiation during which the sick person lays down on a desk while a device points high-powered energy beams to the man's prostate cancer. The other form of radiation therapy is delivered through a process called brachytherapy. In brachytherapy, rice-sized radioactive seeds are implanted into the prostate tissue using an ultrasound-guided needle. Because the seeds eventually decay and stop giving off radiation, they don't need to be removed.

Some of the side effects of radiation therapy include painful or frequent urination, loose stools and erectile dysfunction. There is also the small chance that the radiation could trigger cancer in the rectum, bladder or other parts of the body.

Hormone Therapy

Another option for treating prostate cancer involves using therapy to stop the body's production of testosterone. Given that prostate cancer cells need testosterone to expand, removing their supply of testosterone could usually be an effective therapy for prostate cancer cells. This type of treatment is often used for advanced cases of prostate cancer to shrink tumors and slow down their growth or in early stages of the disease as a preparation for radiation therapy.

Hormone therapy typically involves the use of drugs to either stop the patient's testicles from producing testosterone or prevent testosterone from reaching the cancerous cells. In extreme cases, the testicles can be surgically removed in a procedure called an orchiectomy. This lowers the patient's testosterone levels much more quickly than most medications.

Some of the side effects of hormone therapy include erectile dysfunction, loss of bone mass, hot flashes, weight gain and a reduced sex drive. It could additionally raise the danger of heart disease and cardiac arrest.

Surgery

Prostate cancer can also be treated through the surgical removal of the prostate and the surrounding tissue. This is a very invasive procedure that can be performed in a number of different ways. Your doctor will be able to help you decide what method is best for you should you require this treatment. Adverse effects could consist of urinary incontinence and erectile dysfunction.

View the original article here

Fish Oil Tied to Prostate Risk

ABC News’ Dr. Raheleh Sarbaziha reports:

The fish oil supplements that millions of American men take each day to cut their risk of heart disease might have a dark side, at least according to a study released today that is sure to generate controversy.

Can fish oil really prevent heart disease?

The new study, published today in the Journal of the National Cancer Institute, suggests that men who have higher levels of omega-3 fatty acids in their system face a 43 percent increased risk of developing prostate cancer and a 71 percent increased risk of the high-grade form of the disease.

To determine this, the researchers relied on data from a past study that examined the blood concentrations of omega-3 polyunsaturated fatty acids in 834 men with prostate cancer and 1,393 men without prostate cancer. When they did this, these researchers found an association between high omega-3 levels and the occurrence of prostate cancer.

Read about the effects of fish oil on breast cancer risk.

Whether the increased level of omega-3 in the men with prostate cancer was from supplements or from oily fish in their diet was unclear. But lead study author Dr. Theodore Brasky of Ohio State University Comprehensive Cancer Center said that no matter the source, the findings suggest that men should be wary of getting too much of the nutrient.

“Men will probably want to talk to their doctors, especially those patients who have been recommended increased fish oil intake,” Brasky said. “They should probably moderate their intake of fatty fish and they should avoid fish oil supplements at this time, especially considering that when men are taking fish oil supplementation they are taking [higher doses than they need].”

But some experts say more evidence is needed before men make drastic changes. ABC News Chief Health and Medical Editor Dr. Richard Besser said that the original study from which this data was drawn was not specifically designed to look at the exact relationship between omega-3 fatty acid intake and prostate cancer, so men should think twice before discontinuing them entirely.

“This is not proof that omega 3′s cause prostate cancer,” he said.

If anything, Besser added, the finding should reinforce the notion that better dietary health does not necessarily come in a pill form.

“If you want omega 3′s, get them from food,” he said. “The more we look at supplements, the more untoward consequences we find.”

Read about the dangers of mixing supplements with medications.

Doctor’s Take

So where does this leave men who, based on this study, are worried that they will have to choose between a healthy heart and a healthy prostate?

The first thing that these men should do is speak to their doctors prior to making any changes to their diets and discontinuing current supplementation. In particular, men with active heart conditions or elevated cholesterol levels should approach their cardiologists and discuss the risk versus the benefits of consuming fatty fish and fish oil supplementation.

View the original article here

Diagnosis of Prostate Cancer

The cause of prostate cancer is unknown. It is known, however, that the growth of normal cells and cancerous prostate is stimulated by male hormones, particularly testosterone.

Compared to other cancers, prostate cancer develops relatively slowly. In fact, many men with prostate cancer will not die from the disease, but with the disease. As a man ages, his risk of developing prostate cancer increases. Over 75% of cases are diagnosed in men over 65 years of age.

When a cancerous tumor is small and is located only within the prostate, the cancer is often not detected. The cancer may not cause symptoms and may be too small for a doctor to get it palpable during a routine examination of the prostate. The doctor performs this examination, which receives the name of digital rectal examination (DRE - digital rectal examination), by inserting a finger into the rectum to feel the size and shape of the prostate.

A man can live for many years without finding out they have cancer. As the cancer grows, however, the prostate can eventually squeeze the urethra, which is surrounded by the prostate. Then, symptoms such as difficulty urinating. Generally, this is the first symptom of prostate cancer. (It is important to note, however, that the difficulty in passing urine can be caused by other non-cancerous conditions of the prostate and not always mean that prostate cancer is present).

With or without symptoms, a growing cancer can also start attacking the cells near the prostate. Simultaneously, the cells may be released from cancer and spread to other parts of the body such as the lymph nodes, lungs, and bones, especially the hip bones and lower lumbar region. The most common symptom of this spread is bone pain.

As the primary prostate tumors, tumors that have spread to other parts of the body can expand and compress these other parts.

The American Cancer Society (ACS) has developed guidelines to help doctors detect prostate cancer in its early stages. The ACS recently revised these guidelines to reflect new scientific knowledge. The new guidelines recognize that screening for prostate cancer, including a DRE and annual test to measure prostate-specific antigen (PSA - prostate-specific antigen) in the blood, should be offered to the general male population aged greater than or equal to 50 years of age.

Moreover, men with two or more first degree relatives affected by the disease, or those with african-American origin, should start screening for prostate cancer at an earlier age. Although there is still some disagreement on this matter and until there is more scientific evidence, age 45 years of age may be an appropriate time for men with higher risk begin screening.

There are some circumstances in which prostate cancer screening can not be recommended. How prostate cancer can be a cancer that develops slowly, a man with a life expectancy less than 10 years will probably pass away due to some other disease and probably would not benefit from screening and treatment for prostate cancer. For this reason, the new ACS guidelines include guidance for patients that explains the risks and benefits of screening for prostate cancer.

You and your doctor can discuss the ACS guidelines together and determine if screening is appropriate for you and, if so, when should you start it.

PSA is a substance produced by normal cells and prostate cancer. When prostate cancer is developed or when other prostate disorders are present, the amount of PSA in the blood often increases. The new ACS guidelines advise men with high PSA results showing a doing a biopsy. This will help determine if cancer is actually present.

A PSA test can usually be considered within the normal range when present values between 0 and 4 nanograms per milliliter, sometimes appearing in abbreviated form (ng / ml) in the laboratory report. If the results are within the range above (reported as being greater than 10 ng / ml), certainly doctor may suggest a biopsy.

Sometimes, PSA results are in borderline or gray zone. This occurs when the result is between 4 to 10 ng / ml. The results of the PSA test in this range can be conflicting and not always mean that cancer is present. Certain other conditions, such as benign prostatic hyperplasia (a type of non-cancerous growth of the prostate, also called BPH) and prostatitis (inflammation of the prostate) can cause an abnormal PSA in the test.

If your doctor believes that the rise in PSA is due to benign disease (eg, prostatitis) you may have to wait and repeat the PSA test a few months later and, if necessary, a biopsy later. The new ACS guidelines suggest a biopsy for any man with abnormal DRE results, even if the PSA is normal.

Because of PSA testing in the gray zone may be conflicting, your doctor may advise you to take one or more PSA tests more modern.

The percentage ratio of free PSA / total PSA is a blood test that measures the amount of PSA circulates free (unbound) amount bound in the blood and other blood proteins. If the PSA results are borderline and the percentage ratio of free PSA is low (less than or equal to 10%) then it is more likely that prostate cancer is present. If this is the case, a biopsy may be needed. If the results of the percentage ratio of free PSA are normal, even with a borderline PSA, biopsy is not required.

Another way to examine the PSA involves the adoption of the reference values for PSA specific to different age groups. Higher levels of PSA are normally observed more frequently in men with older ages than at younger men, even without cancer. A range of reference values for PSA specific to different age groups compares the results of the men within the same age group. If PSA levels are high for a man in relation to his own age group, then there is a greater chance that prostate cancer is present.

In men with older ages with results of borderline PSA, this comparison can be more useful than conflicting. As a result, the reference values for PSA specific to different age groups are not routinely adopted.

If your PSA level has already been measured and a TRUS (Transrectal Ultrasound) has also been performed, then it can be determined PSA density (PSAD). To determine which is the PSAD, your doctor will divide the numerical value of serum PSA by size, or prostate volume (the results of TRUS). The chance of getting prostate cancer is higher when the PSAD is high.

Finally, PSA velocity will show how quickly the PSA level increases during a period of time. Two or more PSA tests are often required during the course of several months. Although PSA velocity may be useful in helping your doctor to better interpret the result borderline PSA, in fact she is not used to diagnose prostate cancer. Instead, it is mostly used as a tool to keep track of how their PSA levels are compared for a certain period of time.

Often the PSA increases as part of the natural aging process, an increase in PSA that occurs from time to time does not necessarily indicate that prostate cancer is present. Furthermore, if the PSA increases very rapidly, ie morfe than 20% from baseline to year (as determined by his physician), there is a possibility of prostate cancer.

If your PSA is borderline or abnormal, your doctor can help you determine which tests are right for you. To detect prostate cancer and to determine the size and extent of spread or stage of the disease, your doctor may perform tests involving palpation of the prostate exam in the internal parts of the body, measure the levels of substances in the blood, and examination samples of prostate cells. Click here for descriptions of specific tests.

View the original article here

Organic Cure for Prostate Cancer

Undoubtedly recognized that cancer is considered the most threatening disease on the planet. This is correct due to the way it doesn't pick on who it might cause its curse. This is not simply because of our many careless or casual habits but is a result of further precise not personal attributed circumstances. It afflicts individuals of nearly every race, gender and age. Among its kinds, cancer of the prostate is the most popular case among males.

Cancer of prostate affects males exclusively. This is a disease that invades a man's sex organs, or the men's prostate specifically, a secretory organ within the reproductive system of males. The majority of prostate diseases tend to be slow in developing, though, there are many situations of more assertive prostate cancer cell development. Levels of diagnosis change greatly world wide, with Asia (south and east) discovering less often compared to European countries, and particularly the United States Of America. This ailment commonly strikes males older than 50.

This disease could cause discomfort, complication during urinating, trouble in sexual activities, or erectile dysfunction. Additional signs are likely to progress in the future phases of the sickness. But, a lot of men suffering from this disease do not have symptoms, didn't endure therapy and consequently die of some other irrelevant reasons that makes it a much more serious threat.

If you happen to be identified as having prostate type of cancer, don't just rush out right into the hospital and endanger yourself to every type of radiotherapy. There are certainly alternate options of fighting it. You must be aware of though that natural treatment for prostate is ideal for lowering any negative issues with cancer furthermore to cure it. But aside from the belief that it is not easy to treat, it could be avoided when you eat balanced and healthy diet along with a correct way of life.

Green tea leaf is a growth substance which can eliminate cancer of prostate. It produces a method of building new blood vessels, permits malignant cells to build and increase by giving them with nutrients and oxygen.

Garlic can be a powerful cancer reversal. An herb not only known as a spice but is considered as a medicine plant. Its organosulfur ingredients are under research for possibility to heal prostate diseases. It is said to could have supplied safety from cell-damaging toxins

Several foods which are helpful in eliminating cancer of prostate commonly are Brussels sprouts, broccoli, cabbage and cauliflower.

When I was diagnosed with Prostate Cancer the world seems to cave in on me, I was scared but determined to find a cure. I wasn't ready to take on surgery and any other medical procedures so I devoted myself to research on organic cure for prostate cancer . I wasn't disappointed as I received a lot of support and my health has never been better.

View the original article here

Foods to Avoid During Prostate Cancer

The foods you take in play a role in the general wellness of the prostate gland. Some foods like soybean products, tomato plants, beans and cruciferous vegetables are suggested to keep it healthy, while other product needs to be prevented. There are many regularly eaten foods which have been associated with greater chances of prostatic problems like cancer of the prostate. By staying away from these foods you could reduce risks.

High-Fat Products

Diet routines containing a significant amount of high-fat Products can adversely impact the health condition of your prostatic gland. Consuming foods loaded with saturated fats like red meats and whole fat dairy products increases your danger of developing prostatic adenocarcinoma. To lessen the danger make sure you keep away from these and maintain your saturated fat consumption to 10% of your daily calories. Most of your fat calories must originate from unsaturated fats.

Low-Fiber Products

Consuming products that have very little to no dietary fiber increases your danger of prostatic problems. Abstain from low-fiber foods like white bread, white pasta, white rice, white flour and white sugar. Fast food choices are frequently low in fiber and must be averted to maintain a healthy prostatic gland. On the other hand, a high-fiber diet plan often helps lower risk of developing prostatic adenocarcinoma.

Milk

Dairy products have been associated with increased risks of prostatic adenocarcinoma. Milk boosts the level of insulin-like growth factor in your blood and this particular boost can promote the development of prostatic adenocarcinoma cells. Also, the high calcium quantities in milk can result in a reduction in vitamin D, and decreased vitamin D amounts are connected with prostatic cancer. To decrease your risk substitute your dairy milk with soy milk or give up the use of milk completely.

High Calcium Products

Diet routines which are frequently high in calcium have been associated with elevated risks of prostatic adenocarcinoma. To prevent prostatic gland issues you need to maintain your regular calcium consumption less than 1,500 mg a day. Should you take a multivitamin pill be sure that the calcium amount is not raising your calcium amounts above what's going to raise your risk of prostatic problems.

Alcohol

Alcohol consumption must be kept to average amounts to keep the prostate gland healthy. Consistent heavy drinking increases your threat of developing the more aggressive types of cancer of the prostate. Avoid consuming over 2 alcohol-based drinks each day; this can also help you prevent an increased prostate.

Processed Foods

Highly processed foods usually consist of increased levels of nutritionally poor calories. Consuming these regularly can result in unwanted fat gain, that could raise your threat of prostatic adenocarcinoma along with other prostate issues like erectile dysfunction. Additionally, stuffing up on processed foods might leave you lacking of a number of the nutrients and vitamins that prevent cancer of the prostate, like lycopene and phytoestrogens.

I have a friend who has prostate cancer and I went with him to see his doctor. He asked his doctor regarding foods he wanted to eat, and his doctor gave him the list of foods he should avoid. It was a very comprehensive list but very helpful. This natural treatment for prostate cancer can truly aid in your healing.

View the original article here

Low-Risk Prostate Cancer, Observation Safe And Cost-Effective

Editor's Choice
Academic Journal
Main Category: Prostate / Prostate Cancer
Also Included In: Cancer / Oncology;??Urology / Nephrology
Article Date: 18 Jun 2013 - 0:00 PDT Current ratings for:
Low-Risk Prostate Cancer, Observation Safe And Cost-Effective

Observation is safe, cost-effective, and results in a better quality of life for patients with low-risk, localized prostate cancer, rather than undergoing immediate treatment, says a study carried out at Massachusetts General Hospital and the Dana-Farber Cancer Institute.

The study findings were published in Annals of Internal Medicine.

According to the authors, their statistical models demonstrated that for 70% of men with low-risk prostate cancer at diagnosis "observation is a reasonable and, in some situations, cost-saving alternative to initial treatment."

Julia Hayes, MD, and team believe that their findings confirm that active surveillance and watchful waiting, often referred to as observation, is a reasonable option with low-risk prostate cancer - an option that is underused.

Dr. Hayes said:

"About 70 percent of men in this country have low-risk prostate cancer, and it's estimated that 60 percent of them are treated unnecessarily."

This is a huge number of patients with low-risk prostate cancer who either receive some form of radiation therapy or undergo a radical prostatectomy (their prostate gland is surgically removed), and face the pain and discomfort of treatment, plus the risk of urinary incontinence and erectile dysfunction.

Localized Prostate Cancer - Removal No Better Than Observation - the (low) risk of death over a 12-year period for newly diagnosed patients with low-risk prostate cancer who underwent a radical prostatectomy is the same as for those who opted for observation, according to a clinical trial called PIVOT, which was published online on 19 July in the New England Journal of Medicine.

Dr. Hayes and colleagues looked at a range of scenarios using mathematical models they had created. They concentrated on male seniors aged between 65 and 75 at diagnosis. They also compared estimated costs that are associated with several forms of observation and treatment.

Patients who are advised to undergo active surveillance and chose this option: Undergo a blood test every three months to measure levels of PSA (prostate specific antigenUndergo a rectal examination twice a yearHave a prostate gland biopsy at one year and then every three yearsIf things remain the same - PSA levels stay fairly constant, rectal examinations reveal nothing unusual, and the biopsies results show the prostate cancer continues to be low risk - the "watchful waiting" continues. If at any time tests show that the cancer has become more aggressive, or is more aggressive than originally thought, treatment aimed at curing the disease begins. Hayes said "This approach could also be described as deferred treatment." Patients with low-risk, localized prostate cancer who opt for treatment to cure the disease may undergo: Radical prostatectomy - surgery to remove the prostate gland and some of the tissue around it.IMRT - intensity-modulated radiation therapy. This is a type of 3-dimensional radiation therapy. Computer-generated images are used to show the shape and size of the tumor. Thin radiation beams of different intensities are aimed at the tumor from several angles. With this type of radiation therapy there is less damage to healthy tissue close to the tumor.Brachytherapy - radioactive seed implants are placed within or near to the tumor. Sometimes known as internal radiation therapy or implant radiation therapy.The team calculated and compared the quality-adjusted life expectancy (QALE) for patients undergoing observation versus treatment.

QALE measures both the quality and the quantity of life lived - it is a measure of disease burden. Quantity of life lived is easy to measure. Factors that influence quality of life include having to undergo invasive tests, the impact of the treatment, disease recurrence, and complications.

The investigators also calculated what the lifetime costs are for each strategy. They ranged from $48,699 for a 65-year old man treated with IMRT therapy to $18,302 for a 75 year-old patient who opted for watchful waiting.

For patients newly diagnosed with localized, low-risk prostate cancer, the researchers concluded that: observation is more effective than initial treatmentobservation in some cases is less expensive than initial treatmentobservation yielded 11 months more QALE than brachytherapy (the most effective treatment)observation yielded 11 months more QALE than radical prostatectomy (the least effective treatment)The team admitted that their study made assumptions based on limited research data, but concluded that:

"It appears that active surveillance and watchful waiting are safe alternatives to initial treatment for prostate cancer based on these assumptions. But it's important to emphasize that these decisions are very much a matter of individual choice."

Co-author Philip Kantoff, MD, said "This study delineates the cost benefit of active surveillance as well as watchful waiting - the less aggressive assessment strategy. A previous study by Dr. Hayes and colleagues demonstrated that active surveillance is a reasonable option for men with low-risk disease and associated with a better quality of life. As non-treatment becomes a more accepted option for these patients, selecting those who require less aggressive assessment including biopsy will become important."

A study carried out at the Case Western University School of Medicine in Cleveland, and presented at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting, Los Angeles, in 2007, found that prostate cancer patients who undergo brachytherapy have a 50% lower risk of dying compared to those on watchful waiting/active surveillance.

Prostate cancer patients with low risk tumors may safely defer treatment for many years, researchers from the Beth Israel Deaconess Medical Center reported in the Journal of Clinical Oncology (September 2009 issue).

Study co-author Martin Sanda, MD, said "With the advent of PSA [prostate antigen] screening nearly 20 years ago, we started to detect prostate cancers at much earlier stages. Consequently, while PSA testing has enabled us to successfully begin aggressive treatment of high-risk cancers at an earlier stage, it has also resulted in the diagnosis of cancers that are so small they pose no near-term danger and possibly no long-term danger."

Written by Christian Nordqvist
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Visit our prostate / prostate cancer section for the latest news on this subject. "Observation Versus Initial Treatment for Men With Localized, Low-Risk Prostate Cancer: A Cost-Effectiveness Analysis"
Julia H. Hayes, MD; Daniel A. Ollendorf, MPH; Steven D. Pearson, MD, MSc; Michael J. Barry, MD; Philip W. Kantoff, MD; Pablo A. Lee, BS; and Pamela M. McMahon, PhD
Ann Intern Med. 2013;158(12):853-860. doi:10.7326/0003-4819-158-12-201306180-00002 Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Nordqvist, Christian. "Low-Risk Prostate Cancer, Observation Safe And Cost-Effective." Medical News Today. MediLexicon, Intl., 18 Jun. 2013. Web.
24 Jun. 2013. APA

Please note: If no author information is provided, the source is cited instead.

'Low-Risk Prostate Cancer, Observation Safe And Cost-Effective'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

View the original article here

Vegetable Fats Reduce Prostate Cancer Death Risk

Editor's Choice
Academic Journal
Main Category: Prostate / Prostate Cancer
Also Included In: Nutrition / Diet;??Cancer / Oncology;??Neurology / Neuroscience
Article Date: 11 Jun 2013 - 0:00 PDT Current ratings for:
Vegetable Fats Reduce Prostate Cancer Death Risk

Prostate cancer patients who replace animal fats and some carbohydrates with vegetable fats have a lower risk of premature death, researchers from the University of California reported in JAMA Internal Medicine.

In the United States alone, nearly 2.5 million men currently live with prostate cancer. Not much is known about how diet may influence prostate cancer progression and death rates, the authors wrote as background information.

Erin L. Richman, Sc.D., and team carried out a study involving 4,577 men from the Health Professional Follow-up Study with non-metastatic prostate cancer between 1986 and 2010. They focused on the patients' dietary fat intake after diagnosis. Every four years, they completed questionnaires which asked how often they ate and drank over 130 different types of foods and drinks.

Over a follow-up period of 8.4 years, 315 men died from prostate cancer and 1,064 died from any cause. Those who replaced 10% of their dietary calorific intake of carbohydrates with vegetable fat had a 29% lower risk of lethal prostate cancer and a 26% lower risk of death from any cause.

The authors wrote:

"In this prospective analysis, vegetable fat intake after diagnosis was associated with a lower risk of lethal prostate cancer and all-cause mortality."

The results of this study go against what many doctors advise their recently diagnosed prostate cancer patients to do, which is "Cut out all fats from your diet". The right advice appears to be to tell the patient to consume more fat, fewer carbohydrates, and to make sure the fats come from plants and not animals.

The authors concluded:

"Overall, our findings support counseling men with prostate cancer to follow a heart-healthy diet in which carbohydrate calories are replaced with unsaturated oils and nuts to reduce the risk of all-cause mortality. ... The potential benefit of vegetable fat consumption for prostate cancer-specific outcomes merits further research."

Dr. Stephen J. Freedland, from Duke University Medical Center, Durham, North Carolina wrote in an invited Commentary:

"Using data from food frequency questionnaires completed every four years during follow-up, they found that men who consumed more vegetable fat had a lower risk of prostate cancer death.

Thus, in the absence of randomized trial data, it is impossible to use these data as 'proof' that vegetable intake lowers prostate cancer risk, and the authors have carefully avoided such statements.

Dr. Freedland says that the only modifiable risk factor associated with prostate cancer death risk is obesity. In other words, if you are diagnosed with prostate cancer, make sure you don't become obese, and if you are, lose weight.

How to avoid becoming or remaining obese remains unclear, although Richman and team's study suggests that switching from animal fats and some carbohydrates to vegetable fats may have some benefit.

Freedland concluded that "Determining whether this benefit is due to reduced consumption of carbohydrates or greater intake of vegetables will require future prospective randomized trials."

Low fat diet with fish oil supplements slow down prostate cancer progression

Scientists from UCLA's Jonsson Comprehensive Cancer Center reported in the American Association for Cancer Research that men who ate a low-fat diet with fish oil supplements had slower progressing prostate cancer compared to those on a traditional Western diet that was high in fat.

The researchers also found that the participants on a low-fat, fish oil supplement diet were able to change the structure of the cell membranes in both healthy and malignant cells in the prostate. They wrote "They had increased levels of omega-3 fatty acids from fish oil and decreased levels of omega-6 fatty acids from corn oil in the cell membranes, which may directly affect the biology of the cells, though further studies are needed."

When blood samples were tested in a test tube, the team found that the growth of prostate cancer cells was much slower among the men on the low-fat, fish oil supplement diet.

Mediterranean diet reduces prostate cancer risk

An article published in UroToday showed that a traditional Cretan Mediterranean diet may help reduce the risk of prostate cancer. A typical diet from Crete, a Greek island in the Mediterranean, is based on plenty of plant foods (vegetables, fruits, wholegrain cereals, legumes and nuts), olive oil as the main source of dietary fat, low red meat consumption, moderate to low consumption of dairy products, moderate to high fish intake, and moderate intake of wine (consumed mainly with meals).

The authors added that the Mediterranean diet has other health benefits and can help protect against cardiovascular and cancer mortality, as well as Parkinson's and Alzheimer's diseases.

Vegan diet plus exercise may halt/reverse prostate cancer progression

Men with early stage prostate cancer who adopted a vegan diet and did plenty of exercise were more likely to stop and even reverse their cancer progression, researchers from the Department of Urology, the University of California, San Francisco, and the Memorial Sloan-Kettering Cancer Center reported in the Journal of Urology (September 2005 issue).

The authors claimed that theirs was the first randomized, controlled trial that demonstrated clearly that lifestyle changes may influence the progression of any type of cancer.

Written by Christian Nordqvist
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Visit our prostate / prostate cancer section for the latest news on this subject. "Fat Intake After Diagnosis and Risk of Lethal Prostate Cancer and All-Cause Mortality"
Erin L. Richman, ScD; Stacey A. Kenfield, ScD; Jorge E. Chavarro, MD, ScD; Meir J. Stampfer, MD, DrPH; Edward L. Giovannucci, MD, ScD; Walter C. Willett, MD, DrPH; June M. Chan, ScD
JAMA Intern Med. 2013;():1-8. doi:10.1001/jamainternmed.2013.6536

Invited Commentary
"Dietary Fat and Reduced Prostate Cancer Mortality: Does the Type of Fat Matter?Comment on “Fat Intake After Diagnosis and Risk of Lethal Prostate Cancer and All-Cause Mortality”
Stephen J. Freedland, MD
JAMA Intern Med. 2013;():1-2. doi:10.1001/jamainternmed.2013.7744

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Nordqvist, Christian. "Vegetable Fats Reduce Prostate Cancer Death Risk." Medical News Today. MediLexicon, Intl., 11 Jun. 2013. Web.
11 Jun. 2013. APA

Please note: If no author information is provided, the source is cited instead.

'Vegetable Fats Reduce Prostate Cancer Death Risk'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

View the original article here

Avancé de Cancer de la Prostate Xofigo de médicament approuvé par la FDA

Editor's Choice
Main Category: Prostate / Prostate Cancer
Also Included In: Regulatory Affairs / Drug Approvals;??Cancer / Oncology
Article Date: 17 May 2013 - 5:00 PDT Current ratings for:
Advanced Prostate Cancer Drug Xofigo Approved By FDA

Xofigo (radium Ra 223 dichloride) has been approved by the US FDA for symptomatic late-stage (metastatic) castration-resistant prostate cancer that has reached bones but not other organs, i.e. with no known visceral metastatic disease.

The Food and Drug Administration (FDA) approved Xifogo under the priority review program, three months ahead of schedule.

According to an online FDA communique published this week, Xofigo is aimed at male patients whose prostate cancer metastasized despite receiving medical or surgical interventions to reduce testosterone levels.

Testosterone, the male sex hormone, stimulates the growth and spread of prostate cancer. Prostate cancer develops in the prostate, a gland in the male reproductive system located below the bladder and in front of the rectum.

Quoting statistics from the NCI (National Cancer Institute), the FDA informs that approximately 238,590 men in the USA will be diagnosed with prostate cancer this years - 29,720 patients will have died of the disease in 2013.

Metastatic prostate cancer commonly affects bone. Approximately 90% of metastatic prostate cancer patients have evidence of bone metastases. When cancer reaches the bone, the patient is much more vulnerable to skeletal events, which are known to be the main cause of morbidity and death in men with castration-resistant prostate cancer.

The FDA was scheduled to make a decision on Xofigo by August 14th, 2013. However, approval came through early because the medications was reviewed under the FDA's priority review program, which allows for a speedier process if the medication appears to provide safe and effective treatment and no alternative therapy is available. Drugs which offer significant improvements compared to currently available options are sometimes processed through the same program.

Richard Pazdur, M.D., director of the Office of Hematology and Oncology Products in the Center for Drug Evaluation and Research, FDA, said:

"Xofigo binds with minerals in the bone to deliver radiation directly to bone tumors, limiting the damage to the surrounding normal tissues. Xofigo is the second prostate cancer drug approved by the FDA in the past year that demonstrates an ability to extend the survival of men with metastatic prostate cancer."

In August 2012, the FDA approved Xtandi (enzalutamide) for patients with metastatic castration-resistant prostate cancer that has recurred or spread, including those who received medical or surgical therapy to reduce testosterone. Enzalutamide was approved to be taken in combination with another cancer drug, docetaxel.

When considering whether to approve Xofigo, FDA experts looked at data from one human study, the Phase III ALSYMPCA trial involving 809 patients with symptomatic castration-resistant prostate cancer that spread to bones but not other organs. Patients were randomly selected into one of two groups - the Xofigo or placebo plus best standard of care group.

The main endpoint of the study was overall survival. A pre-planned interim analysis showed that patients given Xofigo lived for an average of 14 months, compared to 11.2 months in the placebo group. Experts also looked at an exploratory updated analysis which was done later - data confirmed extended overall survival among those in the Xofigo group.

Xofigo may cause the following side effects: swelling of a foot, leg or ankle, nausea, vomiting, and diarrhea. Some patients may develop anemia (low level of red blood cells), lymphocytopenia (low level of lymphocytes), leukopenia (low level of white blood cells) and/or neutropenia (low level of infection-fighting white blood cells).

According to Bayer HealthCare, the commercial production of Xofigo is currently underway, initial doses should be on the shelves within a few weeks. Bayer has worldwide exclusive marketing rights for Xofigo. In the United Sates, Xofigo will be co-promoted by Bayer HealthCare and Algeta US, LLC.

Kemal Malik, MD, member of the Bayer HealthCare Executive Committee and Head of Global Development, said:

"Xofigo shows a favorable safety profile and has the potential to improve patient outcomes in a completely novel way. Radium 223 emits alpha particles that affect cancer cells in bone metastases and may contribute to a survival improvement. This FDA approval will provide prostate cancer patients and the physicians who care for them with a new and innovative treatment option."

North American Principal Investigator for the pivotal trial, Dr. Oliver Sartor, medical director of the Tulane Cancer Center, said "Most men with advanced prostate cancer develop bone metastases, which can be life-threatening. Xofigo has demonstrated an anti-tumor effect on bone metastases and an overall survival effect in prostate cancer, making it an important addition to the treatment of CRPC (castration-resistant prostate cancer) patients."

Xofigo's active ingredient, radium 223 dichloride (radium 223) is an alpha particle-emitting radioactive therapeutic agent which undermines the development and growth of tumors on bone metastases. According to Bayer "Radium 223 mimics calcium and forms complexes with the bone mineral hydroxyapatite at areas of increased bone turnover, such as bone metastases. The high linear energy transfer of alpha emitters may cause double-strand DNA breaks in adjacent cells, resulting in an anti-tumor effect on bone metastases. The alpha particle range from radium 223 is less than 100 micrometers, which may limit damage to the surrounding normal tissue."

EMA (European Medicines Agency) has not yet approved Radium 223, neither has any other non-US regulatory body. Bayer says it has submitted a Marketing Authorization Application to EMA for Radium 2234 in December 2012 for the treatment of castration-resistant prostate cancer.

Written by Christian Nordqvist
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Visit our prostate / prostate cancer section for the latest news on this subject. Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Nordqvist, Christian. "Advanced Prostate Cancer Drug Xofigo Approved By FDA." Medical News Today. MediLexicon, Intl., 17 May. 2013. Web.
20 May. 2013. APA

Please note: If no author information is provided, the source is cited instead.

'Advanced Prostate Cancer Drug Xofigo Approved By FDA'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

View the original article here